Animal studies on the reduction and/or dilution of 2-deoxy-2- [18F]fluoro-D-glucose (FDG) activity in the urinary system

Annals of Nuclear Medicine

Volumn 11, Issue 3, 1997, Pages 213-218

  Kosuda, Shigeru ^a,b   Fisher, Susan ^a   Wahl, Richard L ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

L lysine; Urinary system

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FUROSEMIDE; LYSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; DRUG UPTAKE; FEMALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; RENAL SYSTEM PARAMETERS; STATISTICAL ANALYSIS; URINARY EXCRETION; URINE VOLUME; UROGENITAL TRACT TUMOR;

EID: 0030867431     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03164766     Document Type: Article

References (37)

1. Som P, Atkins HL, Bandoypadhyay D, Fowler JS, MacGregor RR, Matsui K, et al. A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med 21: 670-675, 1980.
2. Larson SM, Weiden PL, Grunbaum Z, et al: Positron imaging feasibility studies. II. Characteristic of deoxyglucose uptake in rodent and canine neoplasms: concise communication. J Nucl Med 22: 875-879, 1981.
3. 18FDG uptake in human tumor xenografts: feasibility studies for cancer imaging, J Nucl Med 31: 912, 1989.
4. 18F]fluoro-D-glucose for the detection of tumor involvement in lymph nodes. J Nucl Med 31: 1831-1835, 1990.
5. Higashi K, Clavo AC, Wahl RL. In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy. J Nucl Med 34: 773-779, 1993.
6. Whal RL. Positron emission tomography: application in oncology. In: Murray PC, Ell PJ, eds. Nuclear Medicine in Clinical and Treatment. Edinburgh: Churchill Livingstone, pp. 801-820, 1994.
7. 18F)fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography. J Ural 145: 279-283, 1991.
8. 18F]fluoro-D-glucose (FDG) in patients with renal cell carcinoma (preliminary report). KAKU IGAKU (Jpn J Nucl Med) 25: 1143-1148, 1988.
9. 18F)-fluoro-D-glucose: pilot animal and human studies. J Urol 146: 1470-1474, 1991.
10. 18F]fluoro-2-deoxy-D-glucose. J Compt Assist Tomogr 17: 582-589, 1993.
11. Brown RS, Fisher SJ, Wahl RL. Autoradiographic evaluation of the intra-tumoral distribution of 2-deoxy-D-glucose and monoclonal antibodies in xenografts of human ovarian adenocarcinoma. J Nucl Med 34: 75-82, 1993.
12. Wahl RL, Greenough R, Clark MF, Grossman HB. Initial evaluation of FDG/PET imaging of metastatic testicular neoplasms. J Nucl Med 34: 6p, 1993. (abstract)
13. Wahl RL, Hutchins GD, Roberts J. FDG PET imaging of ovarian cancer: Initial evaluation in patients. J Nucl Med 32: 982, 1991.
14. Hammond PJ, Wade AF, Gwilliam ME, Peters AM, Myers MJ, Gilbey SG, et al. Amino acid infusion blocks renal tubular uptake of indium-labelled somatostatin analogue. Br J Cancer 67: 1437-1439, 1993.
15. Pimm MV, Gribben SJ. Prevention of renal tubule reabsorption of radiometal (indium-111) labelled Fab fragment of a monoclonal antibody in mice by systemic administration of lysine. Eur J Nucl Med 21: 663-665, 1994.
16. Behr TM, Sharkey RM, Juweid ME, Blumenthal RD, Dunn RM, Griffiths GL, et al. Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives. Cancer Res 55: 3825-3834, 1995.
17. 18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridium resin. Int J Radiat Appl Instrum 17: 273-279, 1990.
18. Wahl RL, Hawkins RA, Larson SM, Hendee WR, Coleman RE, Holden RW, et al. Proceedings of a National Cancer Institute workshops: PET in oncology - a clinical research agenda. Radiology 193: 604-606, 1994.
19. 18F-labeled 2-deoxy-2-fluoro-D-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals. J Nucl Med 18: 990-996, 1977.
20. 18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes. J Nucl Med 31: 1831-1835, 1990.
21. Morgenson CE, Sølling K. Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids. Scand J Clin Lab Invest 37: 477-486, 1977.
22. Schwegler JS, Silbernagl S, Tamarappoo BK, Welbourne TC. Amino acid transport in the kidney. In: Kiberg MS, Haussinger D, eds. Mammalian Amino Acid Transport. New York: Plenum Press, pp. 233-260, 1992.
23. Bell GI, Kayano T, Buse JB, Burant CF, Takeda J, Lin D, et al. Molecular biology mammalian glucose transporters. Diabetes Care 13: 198-208, 1990.
24. Hediger MA, Rhoads DB. Molecular physiology of sodium-glucose cotransporters. Physiol Rev 74: 993-1026, 1994.
25. Hediger MA, Turk E, Wright EM. Homology of the human intestinal Na+/glucose and Escherichia coli Na+/proline cotransporters. Proc Natl Acad Sci USA 86; 5748-5752, 1989.
26. Ikeda TS, Hwang E-S, Coady MJ, Hirayama BA, Hediger MA, Wright EM. Characterization of a Na+/glucose cotransporter clined from rabbit small intestine. J Membr Biol 110: 87-95, 1989.
27. Cramer SC, Pardridge WM, Hirayama BA, Wright EM. Colocalization of GLUT2 glucose transporter, sodium/ glucose cotransporter, and γ-glutamyl transpeptidase in rat kidney with double-peroxidase immunocytochemistry. Diabetes 42: 766-770, 1992.
28. Knight T, Sansom S, Weinman EJ. Renal tubular absorption of D-glucose, 3-O-methyl-D-glucose and 2-deoxy-o-glucose. Am J Physiol 233: F274-277, 1977.
29. Silverman M, Black J. High affinity phlorizin receptor sites and their relation to the glucose transport mechanism in the proximal tubule of dog kidney. Biochim Biophys Acta 394: 10-30, 1975.
30. Turner RJ, Silverman M. Sugar uptake into brush border vesicles from normal human kidney. Proc Natl Acad Sci USA 74: 2825-2829, 1977.
31. Miller JH, Mullin JM, McAvoy E, Kleinzeller A. Polarity of transport of 2-deoxy-D-glucose and D-glucose by cultured renal epithelia (LLC-PK1). Biochim Biophys Acta 1110: 209-217, 1992.
32. White MF. The transport of cationic amino acids across the plasma membrane of mammalian cells. Biochim Biophys Acta 822: 355-374, 1985.
33. Dornhorst A, Powell SH, Pensky J. Aggraviation by propranolol of hyperglycemic effect of hydrochlorolhiazide in type II diabetics without alternation of insulin secretion. Lancet i: 123-126, 1985.
34. Struthers AD. The choice of antihypertensive therapy in the diabetic patient. Postgrad Med J 61: 563-569, 1985.
35. Sandstrom PE, Sehlin J. Furosemide causes acute and longterm hyperglycaemia and reduce glucose tolerance in mice. Acta Physiol Scand 132: 75-81, 1988.
36. Sandstrom PE, Sehlin J, Amark K. Furosemide treatment causes age-dependent glucose intolerance and islet damage in obese-hyperglycaemic mice. Pharmacol Toxicol 72: 304-309, 1993.
37. Fuhrman FA. Glycogen, glucose tolerance and tissue metabolism in potassium-depleted rats. Am J Physiol 167: 314-320,1951.